2024 U.S. Code > Title 21 > Chapter 9 > Subchapter VII > Part C > Subpart 8 – Fees Relating to Biosimilar Biological Products

2023 U.S. Code > Title 21 > Chapter 9 > Subchapter VII > Part C > Subpart 8 – Fees Relating to Biosimilar Biological Products

2022 U.S. Code > Title 21 > Chapter 9 > Subchapter VII > Part C > Subpart 8 – Fees Relating to Biosimilar Biological Products

2021 U.S. Code > Title 21 > Chapter 9 > Subchapter VII > Part C > Subpart 8 – Fees Relating to Biosimilar Biological Products

2020 U.S. Code > Title 21 > Chapter 9 > Subchapter VII > Part C > Subpart 8 – Fees Relating to Biosimilar Biological Products

2018 U.S. Code > Title 21 > Chapter 9 > Subchapter VII > Part C > Subpart 8 – Fees Relating to Biosimilar Biological Products

2017 U.S. Code > Title 21 > Chapter 9 > Subchapter VII > Part C > Subpart 8 – Fees Relating to Biosimilar Biological Products

2015 U.S. Code > Title 21 > Chapter 9 > Subchapter VII > Part C > Subpart 8 – Fees Relating to Biosimilar Biological Products

2014 U.S. Code > Title 21 > Chapter 9 > Subchapter VII > Part C > Subpart 8 – Fees Relating to Biosimilar Biological Products

2013 U.S. Code > Title 21 > Chapter 9 > Subchapter VII > Part C > Subpart 8 – Fees Relating to Biosimilar Biological Products

2012 U.S. Code > Title 21 > Chapter 9 > Subchapter VII > Part C > Subpart 8 – Fees Relating to Biosimilar Biological Products